Funding for this research was provided by:
National Cancer Institute (ICMIC P50CA114747)
Received: 6 March 2020
Accepted: 28 July 2020
First Online: 28 August 2020
Ethics approval and consent to participate
: The protocol for this study was reviewed and approved by the U.S. Food and Drug Administration (eIND 108509), the Institutional Review Board at Stanford University, and the Scientific Review Committee at the Stanford Cancer Institute.
: Not applicable.
: A.S., A.M., M.B., and N.K. are former employees of Bayer Pharma AG. A.S., A.M., M.B., N.K., and S.B. are now employed at Life Molecular Imaging GmbH.